The limited number of neuroimaging studies to date, especially human studies of PMD and NRXN1 deletion, makes it difficult to make inferences about brain functional and structural development or identify the most robust brain biomarker. Here, NRXN1 is linked to Pelizeaus-Merzbacher spectrum disorder.